Treatment of chronic heart failure

The Lancet

Volumn 340, Issue 8811, 1992, Pages 92-95

  Packer, M ^a  

^a ADDRESS: Division of Circulatory Physiology Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUCINDOLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIGITALIS; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLOSEQUINAN; HYDRALAZINE; INOTROPIC AGENT; METOLAZONE; METOPROLOL; MINOXIDIL; MOLSIDOMINE; NIFEDIPINE; NITRATE; PIMOBENDAN; PROPRANOLOL; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT; VERAPAMIL;

HEART FAILURE; HUMAN; PRIORITY JOURNAL; SHORT SURVEY;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOTONIC AGENTS; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; CLINICAL TRIALS; DIURETICS; HEART FAILURE, CONGESTIVE; HEMODYNAMICS; HUMAN; NEUROSECRETORY SYSTEMS; VASODILATOR AGENTS;

EID: 0026635293     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(92)90406-S     Document Type: Article

References (32)

1. Enhanced metabolic vasodilation secondary to diuretic therapy in decompensated congestive heart failure secondary to coronary artery disease
2. Comparative effects of captopril and digoxin in patients with mild to moderate heart failure
3. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure
4. Inhibition of the metabolism of atrial natriuretic factor causes diuresis and natriuresis in chronic heart failure
5. Vasodilator and inotropic drugs for chronic heart failure: distinguishing hype from hope
6. Prevention and reversal of nitrate tolerance in patients with congestive heart failure
7. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
8. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study
9. Minoxidil in patients with left heart failure: contrasting hemodynamic and clinical effects in a controlled trial
10. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy to isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure
11. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction
12. Pathophysiologic mechanisms underlying the adverse effects of calcium channel blocking drugs in patients with chronic heart failure
13. Flosequinan augments parasympathetic tone and attenuates sympathetic drive in congestive heart failure: demonstration by analysis of heart rate variability
14. Effect of flosequinan on exercise capacity and symptoms in severe heart failure
15. Randomized multicenter double-blind placebo-controlled evaluation of amlodipine in patients with mild-to-moderate heart failure
16. Efficacy of felodipine in congestive heart failure
17. Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure
18. Xamoterol in severe heart failure
19. Effect of oral milrinone on mortality in severe chronic heart failure
20. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure
21. Randomized, double-blind, placebo-controlled, withdrawal study of digoxin in patients with chronic heart failure treated with converting-enzyme inhibitors
22. Sympatho-inhibitory responses to digitalis glycosides in heart failure patients: direct evidence from sympathetic neural recordings
23. Clinical importance of the renin-angiotensin system in chronic heart failure: double-blind comparison of captopril and prazosin
24. Afterload reduction: a comparison of captopril and nifedipine in dilated cardiomyopathy
25. Effects of enalapril on mortality in severe congestive heart failure; results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
26. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
27. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction
28. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction
29. Cardiac myocyte necrosis induced by angiotensin II
30. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial
31. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure
32. Long-term β-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo